Biotech: Page 44

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Alliance BUILDERS

    Susan Dorfman, Skila Karen J. Hanson, Ph.D., BioStrategy Partners Hussain Mooraj, AMR Research Dominic A. Marasco, Innovex Inc., a Quintiles companyy Bill Meisle, GlaxoSmithKline Building alliances, creating relationships, and making the right connections requires a great deal of skill and savvy,...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The MENTORS

    Glen Drummond, Gilead Sciencess Daniel James Schneider, Life Science Commercialization Consultant Peter Marchesini, inVentiv Health Lawrence G. Wright, Ph.D., MedErgy HealthGroup Mentoring takes patience, foresight, and unselfish devotion to furthering the success of others. Creating a corporate ...

    By PharmaVoice Team • July 28, 2009
  • drug shopping cart Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Commercialization, marketing and social media

    As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Technologists

    Lucia (Lucy) Deus, SupplyScape Corp. Joseph A. Tetzlaff, i3 David J. Pasta, ICON Clinical Research Lucia (Lucy) Deus, SupplyScape Corp. Joseph A. Tetzlaff, i3 David J. Pasta, ICON Clinical Research Cutting-edge thinking and solutions are the hallmark of this dynamic group of individuals who are p...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Patient ADVOCATES

    Peg Connelly, Kforce Clinical Research Inc. Paula Garrett, Eli Lilly & Co. Kathy Giusti, Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortiumm Stanley S. Wulf, M.D., F.A.C.O.G., InfoMedics Inc. Emma Sergeant, RGN, RSCN, Fast4wD Ogilvy Lyndi Hirsch, Genentech USA Patie...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Researchers & SCIENTISTS

    Dr. Lee Babiss was the captain of his Ultimate Frisbee team in college. A consummate life-sciences professional, Dr. Lee Babiss, Global Head of Pharma Research at Roche, is an insightful scientist with a love for research and a passion for patients. Dr. Lee Babiss, Roche Dr. Larry Blankstein, Gen...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The CHANGE agents

    Vaughn Anthony, D. Anderson & Co. Jeffrey Berkowitz, Schering-Plough Pharmaceuticals Debbie Botwick, Pfizer Oliver Chateau, GlaxoSmithKline Nancy Corkum, Johnson & Johnson Michelle Dipp, GSK initiative Mary Hensley Evans, imc2 Health and Wellness Frederick Foard, Communications Media Inc....

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Commanders & CHIEFS

    Ahsan Awan, Global CINRG Inc. Ross Bjella, DDN Pharmaceutical Logistics Laurie Cooke, The Healthcare Businesswomen’s Association (HBA) John Farinacci, ResearchPoint Dr. Thomas Hughes, Zafgen Greg Johnson, Strategic Business Research Rick Keefer, Publicis Strategic Solutions Group Tuan Ha Ngoc, AV...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Defining a Career Path in the New Pharmaceutical Era

    Avoiding the Bull’s-Eye When management needs to trim the workforce, there are ways to avoid being the target. The value of an employee increases if he or she has a can-do attitude, is a problem solver, and can react quickly to changes and challenges in the business environment. Binner. AstraZene...

    By Robin Robinson • April 27, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Una Ryan, Ph.D.: Clear Intent

    BY KIM RIBBINK Dr. Una Ryan has made significant inroads in the biotechnology world. Not only has she helped to successfully navigate a company through major change, she has also played a key role in improving business conditions for other biotech companies. Now she is applying her forward-thinki...

    By Kim Ribbink • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    The industry is outsourcing the activities that are going to be core to being prosperous in the future, while hanging on to activities that will provide less and less value. Disruption equals Opportunity Please explain the concept of disruptive innovation and the opportunities this poses for the ...

    By PharmaVoice Team • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New healthcare-related products, services, and companies Rosica Forms Healthcare Division New Healthcare-related Products, Services, and Companies Featured Briefs: Rosica Forms Healthcare Division Otsuka Unveils North American Restructuring Bio-Imaging and PDS Reorganize Under NEW Bioclinica bran...

    By PharmaVoice Team • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Electronic Delivery of CME Gains Popularity Sidebar: Average % of CME Delivered Via Internet Smaller, Refocused Salesforces Could Create Greater Value for Patients Sidebar: Pharma Job Cuts Announced as of October 2008 Ef...

    By PharmaVoice Team • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Help Wanted: Are You Ready for Today’s Job Market? There’s no doubt about it, times are tough. The headlines scream with news about “right sizing," major layoffs due to the economy, and major mergers and acquisitions that are creating redundancies across all functional areas. Even as this issue w...

    By Taren Grom • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Predicting the Future The Business Case for Forecasting

    By Kim Ribbink Risk is an inherent part of the pharmaceutical business — risk of failure in clinical trials, risk that a product won’t achieve regulatory approval, risk that a product underperforms in the market, and risk of withdrawal after adverse reactions and the costly lawsuits that can foll...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    In Every Issue 3 Letter from the Editor 8 Upfront A brief review of industry news at press time 34 PharmaOutlet Kit Howard looks at what makes professional certification valuable. 36 PharmaTrax Sales, marketing, and R&D trends from industry analysts 38 What’s New New healthcare-related produc...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Novartis Oncology’s David Epstein discusses the growing relevance of diagnostics in drug development. Mr. Epstein credits breakthroughs in biology and bioinformatics with an increased understanding of the genome that will enable developers to do a better job of matching the right drug with the ri...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Dr. Charles BOWDEN Peter TAM Vivus Announces Two Promotions Vivus, a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, has promoted two of its senior executives. Charles Bowden, M.D., has been promoted to senior director, ...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New healthcare-related products, services, and companies TGaS Advisors Offers Regulatory Service TGaS Advisors has launched the next generation of its Commercial Compliance Benchmark (CCB) to help companies navigate in a demanding and evolving regulatory environment. The new benchmark expands and...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Investment Portfolio R&D Spending by U.S. Biopharmaceutical Companies Increases 3% in 2008 A new report reveals that R&D investment in new medicines by the biopharmaceutical industry was $65.2 billion in 2008, an increase of 3% from 2007, according to a combined analysis conducted by Burr...

    By PharmaVoice Team • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Where do we go from here? There’s no getting away from it. It dominates the news. Everybody is talking about it. It, of course, is the economy. “Now, more than ever, in these economic times …" seems to be the theme of every news story (hard and soft), financial pundit, TV program, commercial, etc...

    By Taren Grom • March 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Improving Health Literacy

    The statistics are staggering: As many as 90 millions Americans are functionally healthcare illiterate and low health literacy skills cost the U.S.health system about $73 billion.The industry is beginning to school itself in ways to address this national healthcare issue. BY TAREN GROM The health...

    By PharmaVoice Team • March 17, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Elaine Riddell: Measuring Up

    LEADING A MULTIMILLION DOLLAR COMPANY AND ENSURING ITS SUCCESS TAKES SEVERAL KEY CHARACTER TRAITS. Clearly there is a need for vision, courage, and the intelligence to identify personal strengths and weaknesses. Add to this mix a passion for the job to inspire managers and staff. “I don’t know wh...

    By PharmaVoice Team • March 17, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    78 J a n u a r y / F e b r u a r y 20 0 2 PharmaVOICE to Dr. Lars Ekman, president of bio pharmaceutical R&D. Dr. Pilgrim received her M.D. and Ph.D. from Oxford University. Robert P. LUCIANO LongServing Executive Retires from ScheringPlough Board Chairman emeri tus and a director of Schering...

    By PharmaVoice Team • March 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    Ventiv Health Inc., MDS Pharma Services,and Paul Capital Partners have joined forces to provide lifesci ences companies with a broad range of development, commercialization,and investment support. The alliance combines the drug discovery and development expertise of MDS Pharma Services,the commer...

    By PharmaVoice Team • March 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Defining GLOBAL

    BY DENISE MYSHKO AND ROBIN ROBINSON KARLA ANDERSON Managing Director, Life Sciences BearingPoint Global is a perspective of looking at the business in its totality, not just at a given market or a given country or a given set of rules and regulations, but at the business as a whole. It’s always c...

    By Denise Myshko and Robin Robinson • March 1, 2009